Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 51 | 69 | 107 | 63 | 98 |
| Cost of Goods | 22 | 31 | 55 | 38 | 37 |
| Gross Profit | 29 | 37 | 52 | 25 | 61 |
| Operating Expenses | 8,560 | 7,505 | 7,241 | 6,783 | 6,385 |
| Operating Income | -8,509 | -7,436 | -7,134 | -6,720 | -6,286 |
| Other Income | 15 | 514 | 932 | 517 | 127 |
| Pre-tax Income | -8,494 | -6,923 | -6,202 | -6,204 | -6,160 |
| Income Tax | -2 | 5 | N/A | N/A | -3 |
| Net Income Continuous | -8,492 | -6,928 | -6,202 | -6,204 | -6,157 |
| Net Income | $-8,492 | $-6,928 | $-6,202 | $-6,204 | $-6,157 |
| EPS Basic Total Ops | -0.51 | -0.49 | -0.43 | -0.43 | -0.43 |
| EPS Basic Continuous Ops | -0.51 | -0.48 | -0.43 | -0.43 | -0.43 |
| EPS Diluted Total Ops | -0.51 | -0.49 | -0.43 | -0.43 | -0.43 |
| EPS Diluted Continuous Ops | -0.51 | -0.48 | -0.43 | -0.43 | -0.43 |
| EBITDA(a) | $-7,333 | $-6,576 | $-6,378 | $-6,021 | $-5,617 |